|
1
|
Otto MEB, Martins AMA, Campos Dall'Orto
AOM, Leite SF, de Queiroz Mauricio Filho MAF, Martins NT, de Araújo
SR, Almeida SV, Paiva MUB and Atik FA: Acute cellular rejection in
heart transplant patients: Insights of global longitudinal strain,
myocardial work, and an exclusive group of chagas disease. Front
Cardiovasc Med. 9(841698)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Suzuki N, Kamataki A, Yamaki J and Homma
Y: Characterization of circulating DNA in healthy human plasma.
Clin Chim Acta. 387:55–58. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Beck J, Bierau S, Balzer S, Andag R,
Kanzow P, Schmitz J, Gaedcke J, Moerer O, Slotta JE, Walson P, et
al: Digital droplet PCR for rapid quantification of donor DNA in
the circulation of transplant recipients as a potential universal
biomarker of graft injury. Clin Chem. 59:1732–1741. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schütz E, Fischer A, Beck J, Harden M,
Koch M, Wuensch T, Stockmann M, Nashan B, Kollmar O, Matthaei J, et
al: Graft-derived cell-free DNA, a noninvasive early rejection and
graft damage marker in liver transplantation: A prospective,
observational, multicenter cohort study. PLoS Med.
14(e1002286)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kustanovich A, Schwartz R, Peretz T and
Grinshpun A: Life and death of circulating cell-free DNA. Cancer
Biol Ther. 20:1057–1067. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
De Vlaminck I, Valantine HA, Snyder TM,
Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D,
Weisshaar D, et al: Circulating cell-free DNA enables noninvasive
diagnosis of heart transplant rejection. Sci Transl Med.
6(241ra77)2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hidestrand M, Tomita-Mitchell A,
Hidestrand PM, Oliphant A, Goetsch M, Stamm K, Liang HL,
Castleberry C, Benson DW, Stendahl G, et al: Highly sensitive
noninvasive cardiac transplant rejection monitoring using targeted
quantification of donor-specific cell-free deoxyribonucleic acid. J
Am Coll Cardiol. 63:1224–1226. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Whitlam JB, Ling L, Skene A, Kanellis J,
Ierino FL, Slater HR, Bruno DL and Power DA: Diagnostic application
of kidney allograft-derived absolute cell-free DNA levels during
transplant dysfunction. Am J Transplant. 19:1037–1049.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Oellerich M, Shipkova M, Asendorf T,
Walson PD, Schauerte V, Mettenmeyer N, Kabakchiev M, Hasche G,
Gröne HJ, Friede T, et al: Absolute quantification of donor-derived
cell-free DNA as a marker of rejection and graft injury in kidney
transplantation: Results from a prospective observational study. Am
J Transplant. 19:3087–3099. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Oellerich M, Budde K, Osmanodja B,
Bornemann-Kolatzki K, Beck J, Schütz E and Walson PD: Donor-derived
cell-free DNA as a diagnostic tool in transplantation. Front Genet.
13(1031894)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Beck J, Oellerich M, Schulz U, Schauerte
V, Reinhard L, Fuchs U, Knabbe C, Zittermann A, Olbricht C, Gummert
JF, et al: Donor-derived cell-free DNA is a novel universal
biomarker for allograft rejection in solid organ transplantation.
Transplant Proc. 47:2400–2403. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gielis EM, Beirnaert C, Dendooven A,
Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W,
Emonds MP, De Winter BY, et al: Plasma donor-derived cell-free DNA
kinetics after kidney transplantation using a single tube multiplex
PCR assay. PLoS One. 13(e0208207)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Berry GJ, Burke MM, Andersen C, Bruneval
P, Fedrigo M, Fishbein MC, Goddard M, Hammond EH, Leone O, Marboe
C, et al: The 2013 international society for heart and lung
transplantation working formulation for the standardization of
nomenclature in the pathologic diagnosis of antibody-mediated
rejection in heart transplantation. J Heart Lung Transplant.
32:1147–1162. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Stewart S, Winters GL, Fishbein MC,
Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A,
Berry GJ, Burke MM, et al: Revision of the 1990 working formulation
for the standardization of nomenclature in the diagnosis of heart
rejection. J Heart Lung Transplant. 24:1710–1720. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cooper LT, Baughman KL, Feldman AM,
Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC,
Towbin J, et al: The role of endomyocardial biopsy in the
management of cardiovascular disease: A scientific statement from
the American heart association, the American college of cardiology,
and the European society of cardiology. Circulation. 116:2216–2233.
2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Beck J, Oellerich M and Schütz E: A
universal droplet digital PCR approach for monitoring of graft
health after transplantation using a preselected SNP set. Methods
Mol Biol. 1768:335–348. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Altman DG and Bland JM: Measurement in
medicine: The analysis of method comparison studies. Statistician.
32:307–317. 1983.
|
|
18
|
Agbor-Enoh S, Shah P, Tunc I, Hsu S,
Russell S, Feller E, Shah K, Rodrigo ME, Najjar SS, Kong H, et al:
Cell-free DNA to detect heart allograft acute rejection.
Circulation. 143:1184–1197. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yardan T, Altintop L, Baydin A, Yilmaz O
and Guven H: B-type natriuretic peptide as an indicator of right
ventricular dysfunction in acute pulmonary embolism. Int J Clin
Pract. 62:1177–1182. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lan YT, Chang RKR, Alejos JC, Burch C and
Wetzel GT: B-type natriuretic peptide in children after cardiac
transplantation. J Heart Lung Transplant. 23:558–563.
2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gielis EM, Ledeganck KJ, Dendooven A,
Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S,
Van Biesen W, Emonds MP, et al: The use of plasma donor-derived,
cell-free DNA to monitor acute rejection after kidney
transplantation. Nephrol Dial Transplant. 35:714–721.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Macher HC, García-Fernández N,
Adsuar-Gómez A, Porras-López M, González-Calle A, Noval-Padillo J,
Guerrero JM, Molinero P, Borrego-Domínguez JM, Herruzo-Avilés Á and
Rubio A: Donor-specific circulating cell free DNA as a noninvasive
biomarker of graft injury in heart transplantation. Clin Chim Acta.
495:590–597. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
(https://www.cksonline.cz/31-vyrocni-sjezd-cks/sjezd.php?p=read_abstrakt_program&idabstrakta=370&act=print#:~:text=Conclusion%3A%20Individual%20monitoring%20of%20ddcfDNA,patients%20suffering%20ACR%20or%20AMR.
|
|
24
|
World Medical Association. World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
